ABINGDON, England, September 3, 2015 /PRNewswire/ --
Atopix Therapeutics Limited ("Atopix"), a UK biotechnology company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announces the appointment of Dr Andrew Zambanini as Chief Medical Officer.
Dr...